1. Cohn L, Elias JA, Chupp GL. Asthma: Mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789–815.
2. Randolph DA, Stephens R, Carruthers CJ, Chaplin DD. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104:1021–1029.
3. del Giudice MM, Rocco A, Capristo C. Probiotics in the atopic march: highlights and new insights. Dig Liver Dis 2006; 38:S288-290.
4. Mohaghegh HS, Khanbaba CR, Mazaheri B, Gharagozlo MJ. A novel and invasive metastatic adenocarcinoma of breast cancer (HAZ-1) in small laboratory mice. 14th Iranian congress of Physiology and Pharmacology 1999; p.262.
5. Mohaghegh HS, Nasiri Khalaji S, Mohtarami F, Rahimi A. G2, PC and G2F in allergic asthma. Iran J Pediatr 2004; 13:30-33.
6. Neamati A, Boskabady MH, Afshari JT, Mohaghegh Hazrati S, Rohani A. The effect of natural adjuvants on tracheal responsiveness on cell count in lung lavage of sensitized guinea pigs. Respirology 2009; 14:877-884.
7. Annesi-Maesano I. Asthma epidemiology. Rev Prat 2005; 55:1295-1298.
8.Tarlo SM. Prevention of occupational asthma in Ontario. Can J Physiol Pharmacol 2007; 85:167-172.
9. Arshad SH. Primary prevention of asthma and allergy. J Allergy Clin Immunol 2005; 116:3-14.
10.Devereux G. Early life events in asthma--diet. Pediatr Pulmonol 2007; 42:663-673.
11.Sullivan SD, Melyzer EO. Emerging therapeutic strategies for asthma anagement. J Manag Care Pharm 2003; 9:14-21.
12.Tsitoura DC, Tassios Y. Immunomodulation: the future cure for allergic diseases. Ann N Y Acad Sci 2006; 1088:100-115.
13.Prescott SL, Björkstén DB. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007; 120:255-262.
14.Platts-Mills T, Leung DYM, Schatz M. The Role of Allergens in Asthma. Am Fam Physician 2007; 76:675-680.
15.Bloebaum RM, Grant JA, Sur S. Immunomodulation: the future of allergy and asthma treatment. Curr Opin Allergy Clin Immunol 2004; 4:63-67.
16.Sharma S, Jaffe A, Dixon G. Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis. Paediatr Drugs 2007; 9:107-118.
17.Van Rijt LS, Kuipers H, Vos N, Hijdra D, Hoogstenden HC, Lambrecht BN. A rapid flow cytometric method for determining the composition of bronchoalveolar lavage fluid cells of mouse models of asthma. J Immunol Methods 2004; 288:111-121.
18.Yoo J, Tcheurekdjian H, Lynch SV, Cabana M, Boushey HA. Microbial manipulation of immune function for asthma prevention; inferences from clinical trials. Proc Am Thorac Soc 2007; 4:277-282.